Divarasib
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Divarasib, covering 2025-01-03 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) [Phase 3]